Re­genxbio, UPenn file patent suit against Sarep­ta re­lat­ed to new Duchenne gene ther­a­py

Re­genxbio, a Rockville, MD-based biotech, and the Uni­ver­si­ty of Penn­syl­va­nia sued Sarep­ta Ther­a­peu­tics for the sec­ond time, this time al­leg­ing patent in­fringe­ment for the com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER